论文部分内容阅读
目的:本次研究主要分析在多囊卵巢综合征内分泌紊乱患者的治疗当中采用胰岛素增敏剂治疗的临床效果。方法:本次研究范围限定在本院2016年1月-2017年1月间收治的多囊卵巢综合征内分泌紊乱患者当中,研究样本需求量为60例,采用随机盲选法将其分为对照组与观察组,对照组患者采用戊酸雌二醇片、妈富隆、枸缘酸氯米芬治疗,观察组患者采用胰岛素增敏剂治疗,将两组患者治疗前后的治疗临床总有效率、治疗后排卵率、妊娠率等指标作为对比依据。结果:(1)观察组患者治疗总有效率高于对照组患者(P<0.05);(2)观察组患者治疗后排卵率、妊娠率均高于对照组患者(P<0.05)。结论:在多囊卵巢综合征内分泌紊乱患者的治疗当中采用胰岛素增敏剂治疗,有利于提高治疗效果,改善治疗质量,取得较为显著的预后效果。
Objective: This study mainly analyzed the clinical effect of insulin sensitizer in the treatment of PCOS patients with endocrine disorders. Methods: Among the patients with polycystic ovary syndrome endocrine disorder who were confined to our hospital from January 2016 to January 2017, the study sample required 60 patients and were randomly divided into control The patients in the observation group and the control group were treated with estradiol valerate tablets, marvelon, and clomiphene citrate, and the patients in the observation group were treated with insulin sensitizer. The total effective rate of the two groups of patients before and after treatment, Ovulation rate after treatment, pregnancy rate and other indicators as a basis for comparison. Results: (1) The total effective rate of observation group was higher than that of control group (P <0.05). (2) The ovulation rate and pregnancy rate of observation group were higher than those of control group after treatment (P <0.05). Conclusion: Treatment of patients with PCOS with endocrine disorders using insulin sensitizers is beneficial to improve the therapeutic effect, improve the quality of treatment and achieve more significant prognosis.